. Ionomycin causes activation of p38 and p42/44 mitogen-activated protein kinases in human neutrophils. Am J Physiol Cell Physiol 281: C350-C360, 2001.-Many receptor-linked agents that prime or activate the NADPH oxidase in polymorphonuclear neutrophils (PMNs) elicit changes in cytosolic Ca 2ϩ concentration and activate mitogen-activated protein (MAP) kinases. To investigate the role of Ca 2ϩ in the activation of p38 and p42/44 MAP kinases, we examined the effects of the Ca 2ϩ -selective ionophore ionomycin on priming and activation of the PMN oxidase. Ionomycin caused a rapid rise in cytosolic Ca 2ϩ that was due to both a release of cytosolic Ca 2ϩ stores and Ca 2ϩ influx. Ionomycin also activated (2 M) and primed (20-200 nM) the PMN oxidase. Dual phosphorylation of p38 MAP kinase and phosphorylation of its substrate activating transcription factor-2 were detected at ionomycin concentrations that prime or activate the PMN oxidase, while dual phosphorylation of p42/44 MAP kinase and phosphorylation of its substrate Elk-1 were elicited at 0.2-2 M. SB-203580, a p38 MAP kinase antagonist, inhibited ionomycin-induced activation of the oxidase (68 Ϯ 8%, P Ͻ 0.05) and tyrosine phosphorylation of 105-and 72-kDa proteins; conversely, PD-98059, an inhibitor of MAP/ extracellular signal-related kinase 1, had no effect. Treatment of PMNs with thapsigargin resulted in priming of the oxidase and activation of p38 MAP kinase. Chelation of cytosolic but not extracellular Ca 2ϩ completely inhibited ionomycin activation of p38 MAP kinase, whereas chelation of extracellular Ca 2ϩ abrogated activation of p42/44 MAP kinase. These results demonstrate the importance of changes in cytosolic Ca 2ϩ for MAP kinase activation in PMNs.
cytosolic calcium POLYMORPHONUCLEAR NEUTROPHILS (PMNs) comprise an essential component of host defense against microbial invaders (50, 56) . PMNs circulate freely in the blood stream and exert their major microbicidal functions in the tissues. To perform these microbicidal functions, PMNs migrate to areas of infection by adhesion to the vascular endothelium, diapedesis through the endothelial monolayer, chemotaxis to the site of infection, phagocytosis of microbial invaders, and release of cytotoxic metabolites into the phagolysozome, resulting in killing of the microorganisms (2, 18, 22) . Priming and activation of PMNs are distinct events important for normal PMN function. Priming results in both conformational changes of the ␤ 2 -integrin adhesion molecules, e.g., CD11b/CD18, which increases their avidity for endothelial ligands, including intracellular adhesion molecule-1, and increases the surface expression of CD11b/CD18, which is important for chemotaxis (2, 22) . PMN activation results in the release of maximal amounts of reactive oxygen metabolites and proteases for optimal antimicrobial function. The respiratory burst in PMNs describes the generation of superoxide anions and other toxic oxygen metabolites by the NADPH oxidase, whereby oxygen molecules are reduced to superoxide anions through the electron transfer from NADPH (11) . Receptor-linked agents, such as platelet-activating factor (PAF) and leukotriene B4, can prime the NADPH oxidase, while chemoattractants such as the bacterial tripeptide N-formylmethionyl-leucyl-phenylalanine (FMLP), interleukin-8, and C5a can prime or activate the respiratory burst depending on their concentration (17, 31, 51, 55, 57) . Ca 2ϩ ionophores are small hydrophobic molecules that intercalate into the lipid bilayer of the cell membrane and increase Ca 2ϩ permeability. These increases in cytosolic Ca 2ϩ concentration mediate many cellular functions, including priming and activation of the PMN oxidase (36) . Ionomycin also modulates other PMN functions, including adhesion to endothelial cells, as well as eliciting changes in tyrosine protein phosphorylation (4, 17, 28) . Indeed, changes in cytosolic Ca 2ϩ play an integral role in receptor-mediated signaling in PMNs, and these events are the result of either the release of Ca 2ϩ from intracellular stores (calciosomes) or influx of extracellular Ca 2ϩ , or both (3). Receptor-linked priming and activating agents, e.g., PAF and FMLP, cause rapid rises in cytosolic Ca 2ϩ levels, and these changes in cytosolic Ca 2ϩ are necessary for chemotaxis, protein tyrosine phosphorylation, and in the case of FMLP, oxidase assembly (14, 15, 20, 26, 37, 45) . In addition, extracellular Ca 2ϩ is also required for maximal activity of PMN priming agents, including PAF (15) .
Protein phosphorylation is a prerequisite for many PMN signal transduction pathways, including those that are receptor linked. Many PMN agonists signal through a complex series of protein kinase cascades that include activation of mitogen-activated protein (MAP) kinases (6, 14, 16) . p38 and p42/44 MAP kinases are members of distinct, parallel serine/threonine kinase pathways in PMNs that relay signals from a cell surface receptor to changes in cellular functions including transcription, chemotaxis, and phagocytosis (24, 32, 39, 47) . Both PAF and FMLP cause activation of p38 and p42/44 MAP kinases in PMNs, and these MAP kinase pathways have been implicated in regulating multiple PMN functions, including oxidase activity and chemotaxis (24, 32, 39, 40, 47) . It is important to note that activation of the p38 and p42/44 MAP kinases requires dual phosphorylation of discrete tyrosine and threonine residues (Thr-180/Tyr-182 and Thr-202/Tyr-204, respectively) (7, 27) .
Changes in cytosolic Ca 2ϩ concentration have been implicated in regulation of protein phosphorylation in PMNs, especially for receptor-linked priming and activation of the PMN oxidase by PAF or FMLP (14, 45) . However, newer data have implied that intracellular Ca 2ϩ is not sufficient or necessary for p38 MAP kinase phosphorylation or activity (32) . Because ionomycin directly causes changes in cytosolic Ca 2ϩ concentration, affects multiple PMN functions, and activates PMN signal transduction in a receptor-independent manner, we investigated ionomycin-induced changes in both p38 and p42/44 MAP kinase activity. We hypothesize that ionomycin activates MAP kinases directly through Ca 2ϩ influx, and this Ca 2ϩ influx and MAP kinase activity are important for ionomycin-induced priming and activation of the PMN oxidase.
MATERIALS AND METHODS

Materials.
Cell isolation reagents, electrophoresis materials, ammonium persulfate, cytochrome c, superoxide dismutase, PAF, FMLP, phorbol 12-myristate 13-acetate (PMA), ionomycin, EGTA, leupeptin, phenylmethylsulfonyl fluoride (PMSF), p-nitrophenylphosphate, and sodium orthovanadate were obtained from Sigma Chemical (St. Louis, MO). PD-98059 and SB-203580 were obtained from Calbiochem (La Jolla, CA). Acrylamide, bisacrylamide, and N,N,NЈ,NЈ-tetramethylenediamine were obtained from Bio-Rad (Hercules, CA). Dual phosphospecific antibodies to the p42/44 and p38 MAP kinases (Thr-202/Tyr-204), p38 (activating transcription factor-2 or ATF-2) and p42/44 (Elk-1) MAP kinase activity assay kits, and a horseradish peroxidase-linked goat anti-rabbit secondary antibody were obtained by Cell Signaling Technology (Beverly, MA). An antibody against phosphotyrosine and an enhanced chemiluminescence detection system were purchased from Zymed Laboratories (San Francisco, CA) and Amersham (Chicago, IL), respectively. Indo 1-acetoxymethyl ester (indo 1-AM), 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA)-AM, and thapsigargin were obtained from Molecular Probes (Eugene, OR).
Neutrophil isolation. Whole blood was drawn from healthy human volunteers by venipuncture after obtaining informed consent via a protocol approved by the Colorado Multiple Institution Review Board. PMNs were isolated by dextran sedimentation, Ficoll-Hypaque gradient centrifugation, and hypotonic lysis as previously described (3). Cells were resuspended to a concentration of 2.5 ϫ 10 7 cells/ml in KrebsRinger phosphate buffer with 2% dextrose and used immediately for all subsequent manipulations.
Superoxide anion measurement and cytosolic surements. The maximal rate of superoxide anion generation was measured by monitoring the superoxide dismutase inhibitable reduction of cytochrome c at 550 nm in a Molecular Devices microplate reader (Menlo Park, CA) as previously described (49) . For measuring activation and priming of the PMN oxidase by ionomycin, PMNs were primed in wells for 5 min with 20 nM-20 M ionomycin and subsequently activated with 1 M FMLP. For MAP kinase inhibitor studies, PMNs were incubated for 30 min in the dark at 37°C with 0.1-10 M PD-98059, an inhibitor of MAP/extracellular signal-related kinase (ERK) 1 (MEK1) (IC 50 ϭ 2 M), the upstream kinase that phosphorylates p42/44 MAP kinase, and SB-203580, a p38 MAP kinase inhibitor (IC50 ϭ 0.2-1.0 M) that binds the p38 MAP kinase ATP pocket, or DMSO vehicle (9, 13, 52 . PMN cytosolic Ca 2ϩ levels were determined by indo 1 loading of PMNs and analysis in a PerkinElmer LS50B spectrofluorimeter over real time (PerkinElmer, Norwalk, CT) as previously described employing the Grynkiewicz equation (15, 23) .
MAP kinase immunoblotting. PMNs were pretreated in selected experiments with PD-98059, SB-203580, genistein (100 M), a general tyrosine kinase inhibitor (54) , BAPTA (50 M), or DMSO control at 37°C as described above. The dose of genistein was determined by both examining inhibition of the FMLP-activated respiratory burst and tyrosine phosphorylation over a range of concentrations from 1-100 M, compared with the inactive analog daidzein. Moreover, at the 100-M concentration, genistein does not affect many Ser/Thr protein kinases (1) . PMNs (1.25 ϫ 10 6 , 5 g of protein) were stimulated with 2 nM-2 M ionomycin, 2 M PAF, 1 M FMLP, or DMSO control for 30-300 s and immediately placed in Laemmli digestion buffer with freshly prepared protease inhibitors: 10 g/ml leupeptin, 2 mM sodium orthovanadate, 10 mM p-nitrophenylphosphate, and 1 mM PMSF (34) . It is important to note that the exact numbers of cell equivalents were added to each well. Samples were boiled for 15 min, and the proteins were separated by 10% SDS-PAGE overnight. Gels were subsequently immunoblotted onto nitrocellulose membranes using Towbin Tris-glycine transfer buffer at 4°C (53) . Blots were blocked in 5% skim milk diluted in Tris-buffered saline with 0.1% Tween 20 (Tris buffer), incubated with either dual-phosphorylated p42/44 or p38 MAP kinase antibodies overnight, washed three times with Tris buffer, incubated with a horseradish peroxidaselinked goat anti-rabbit secondary antibody, and subsequently developed on X-ray film using an enhanced chemiluminescence detection system. Densitometry was performed using Scion Image version 4.0.2 downloaded from the National Institutes of Health website, and the densitometry values are expressed in arbitrary units.
MAP kinase activity assays. PMNs were isolated and stimulated for 60 s with differing concentrations (20 nM-2 M) of ionomycin. The PMNs were lysed in a buffer (lysis buffer) containing 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM ␤-glycerol phosphate, 1 mM Na 3VO4, and 1 g/ml leupeptin. The lysate was sonicated four times for 5 s at 4°C, centrifuged at 15,000 g for 10 min at 4°C, and the supernatant was transferred to a fresh tube. The amount of protein was measured by a modified Lowry protein assay, and 200 g of lysate were incubated with a 1:50 dilution of p38 or p42/44 MAP kinase antibody overnight with gentle rocking at 4°C. Protein A-Sepharose beads (20 l) were added to the mixture and incubated for 3 h at 4°C. The mixture was centrifuged at 15,000 g for 30 s at 4°C, and the pellet was washed twice with lysis buffer followed by two washes with 25 mM Tris (pH 7.5), 5 mM ␤-glycerol phosphate, 2 mM dithiothreitol, 0.1 mM Na 3VO4, and 10 mM MgCl2 (kinase buffer). The pellet was resuspended in kinase buffer supplemented with 200 mM ATP and 2 mg ATF-2 fusion protein, and the mixture was incubated for 30 min at 30°C. The reaction was terminated with the addition of Laemmli sample buffer and boiled for 5 min. The proteins were separated by gel electrophoresis, transferred to nitrocellulose, and probed with a phospho-ATF (Thr-71) antibody or a phosphoElk-1 (Ser-383) antibody. The bands were visualized by an enhanced chemiluminescence detection system with subsequent exposure to X-ray film.
Statistical analysis. The mean, SD, and SE of the mean were calculated by standard techniques. Paired analysis of variance, followed by Tukey's post hoc analysis for multiple comparisons, were employed with statistical significance determined at P Ͻ 0.05. Dual phosphorylation and activation of the p38 and p42/44 MAP kinases in PMNs stimulated with ionomycin. Because dual phosphorylation of discrete threonine and tyrosine residues is required for p38 and p42/44 MAP kinase activation, activation of p38 and p42/44 MAP kinases by ionomycin was investigated by Western blotting whole cell extracts with antibodies to dually phosphorylated (Thr-180/Tyr-182) p38 and (Thr-202/Tyr-204) p42/44 MAP kinases (7) . PMNs were stimulated with 2 nM -2 M ionomycin for 1 min, and whole cell lysates were subjected to SDS-PAGE and immunoblotting. In addition, PMNs were stimulated with 2 M PAF or 1 M FMLP as positive controls or with DMSO vehicle control. Samples were taken concurrently from the same aliquot of PMNs for p38 and p42/44 MAP kinase dual phosphorylation to examine differential phosphorylation patterns. Ionomycin stimulation of PMNs for 1 min showed dual phosphorylation of p38 MAP kinase at 20 nM -2 M with the 2 nM dose demonstrating minimal dual phosphorylation of the p38 MAP kinase ( Fig. 2A) . This dual phosphorylation of p38 MAP kinase was similar to the PAF-and FMLP-positive controls, and no dual phosphorylation was detected in the DMSO-treated PMNs. The identical PMN lysates were also subjected to immunoblotting with an antibody against dual-phosphorylated (Thr-202, Tyr-204) p42/44 MAP kinase. Ionomycin elicited dual phosphorylation of p42/44 MAP kinases at concentrations of 200 nM and 2 M, similar to the PAFand FMLP-positive controls (Fig. 2B) . Analogous to the DMSO control, incubation with ionomycin at concentrations of 2-20 nM did not cause dual phosphorylation of p42/44 MAP kinases. Ionomycin stimulation of PMNs resulted in dual phosphorylation of p38 MAP kinase at concentrations (20 nM -2 M) that either primed or activated the PMN oxidase, while dual phosphorylation of p42/44 MAP kinase was elicited at slightly higher doses of ionomycin (200 nM -2 M). As controls, identical aliquots from the same PMNs employed above as well as stripped blots from the above experiments were probed with a monoclonal antibody to p38 and p42/44 MAP kinases. No differences in the amounts of immunoreactivity were visualized among any of the wells (results not shown).
RESULTS
Ionomycin-induced cytosolic
Although dual phosphorylation of both p38 and p42/44 MAP kinases is required for activation of these kinases, the activity of these kinases was determined by assaying phosphorylation of known endogenous substrates of these enzymes. As shown in Fig. 3A , 2 M ionomycin caused phosphorylation of ATF-2, a known substrate of p38 MAP kinase. In addition, both 20 and 200 nM doses of ionomycin also elicited phosphorylation of ATF-2, demonstrating that ionomycin concentrations that caused dual phosphorylation of p38 MAP kinase also caused activation of this enzyme (32, 39) . Similarly, ionomycin concentrations that caused dual phosphorylation of p42/44 MAP kinases (2 M but not 20 nM) also rapidly phosphorylated Elk-1, a recognized substrate of the p42/44 MAP kinases (Fig. 3B) (47) . Thus dual phosphorylation of p38 and p42/44 MAP kinases is equivalent to activation as determined by phosphorylation of well-described substrates of these kinases.
Because ionomycin caused rapid changes in cytosolic Ca 2ϩ concentration, we investigated whether dual phosphorylation of MAP kinases occurred concurrently over the same time interval with the cytosolic Ca 2ϩ transient (Fig. 4) . PMNs were stimulated with 20 nM ionomycin for p38 MAP kinase activation or 2 M ionomycin for p42/44 activation over a time course of 0-10 min and immunoblotted. Twenty nanomolar ionomycin stimulation resulted in detectable p38 MAP kinase dual phosphorylation at 30 s, maximal phosphorylation at 1 min, and diminished phosphorylation at 5 and 10 min (Fig. 4A) . The p42/44 MAP kinase dual phosphorylation, induced by 2 M ionomycin stimulation, was absent at 30 s, detectable at 60 s, maximal at 2 min, was sustained for 5 min, and became diminished at 10 min (Fig. 4B) . The p38 MAP kinase dual phosphorylation in ionomycin-stimulated PMNs occurs concurrently with the cytosolic Ca 2ϩ flux, while the p42/44 MAP kinase dual phosphorylation appears to be delayed compared with the cytosolic Ca 2ϩ flux.
Attenuation of the ionomycin-induced p42/44 MAP kinase dual phosphorylation by genistein and MEK1
inhibition. Because ionomycin stimulation resulted in dual phosphorylation, tyrosine and threonine, of the p38 and p42/44 MAP kinases, we examined the ability to inhibit this dual phosphorylation by employing specific inhibitors: PD-98059, an inhibitor of MEK1, the kinase that phosphorylates p42/44 MAP kinase; genistein, a tyrosine kinase inhibitor; and SB-203580, a p38 MAP kinase inhibitor (9, 13, 52). PMNs were pretreated with DMSO control, 1 -10 M PD-98059, 1-10 M SB-203580, or 100 M genistein for 30 min and subsequently activated with 2 M ionomycin. Genistein pretreatment of PMNs inhibited ionomycininduced dual phosphorylation of p38 MAP kinase (Fig. 5A) , whereas the inactive analog daidzein had no affect (data not shown). Further control data indicated that genistein (100 M) inhibited the FMLPactivated respiratory burst by 62 ϩ 8%, abrogated all of the changes in FMLP-mediated tyrosine protein phosphorylation, and did not decrease PMN viability (trypan blue negativity: 99 ϩ 2% with DMSO, 98 ϩ 3% with 100 M genistein), similar to other reports (19, 35) . Lower genistein doses displayed decreased amounts of inhibition. Further control experiments also showed that the inactive genistein analog daidzein (100 M) had no affect on the FMLP-activated respiratory burst and did not inhibit FMLP-mediated changes in tyrosine protein phosphorylation. As expected, SB-203580 did not cause inhibition of dual phosphorylation of p38 MAP kinase because it is an inhibitor of this MAP kinase, and, in these experiments, SB-203580 served as a negative control. However, both PD-98059 and genistein pretreatment inhibited the dual phosphorylation of p42/44 MAP kinase phosphorylation (Fig. 5B) . In addition, PMNs pretreated with 10 M PD-98059 did not affect the iono- mycin-mediated dual phosphorylation of p38 MAP kinase, nor did preincubation of PMNs with SB-203580 affect dual phosphorylation of p42/44 MAP kinases in response to ionomycin (results not shown). Thus ionophore-stimulated PMNs require genistein-sensitive tyrosine kinases for activation of both p38 and p42/44 MAP kinases as well as MEK1 for activation of p42/44 MAP kinase.
Inhibition of ionomycin-induced oxidase activation with MAP kinase inhibitors. Because p38 and p42/44 MAP kinases were phosphorylated in PMNs stimulated with ionomycin, inhibition of these MAP kinases was investigated to see if activation of these enzymes was required for superoxide generation. PMNs were incubated with MAP kinase inhibitors SB-203580 (p38 MAP kinase inhibitor) and PD-98059 (MEK1 inhibitor) or DMSO (control), as described, over a range of concentrations of 0.1-10 M. The PMNs were then activated with 2 M ionomycin, and superoxide generation was measured (Table 2) . SB-203580 pretreatment inhibited the ionomycin activation of the oxidase over a range of concentrations from 1 to 10 M by 38 Ϯ 9 to 45 Ϯ 13% (P Ͻ 0.05, n ϭ 10). (Fig. 6A) . In contrast, similar experiments done with PMNs stimulated with 2 M ionomycin for 1 min showed inhibition of p42/44 MAP kinase dual phosphorylation with both BAPTA and EGTA pretreatment, compared with DMSO control (Fig. 6B) (41) . To determine whether PKC activation, without altering cytosolic Ca 2ϩ concentration, causes rapid activation of p42/44 MAP kinases, PMNs (1 ϫ 10 6 /well) were treated with 200 ng/ml of PMA over a time course of 30-300 s and lysed. The proteins were separated and probed with an antibody to activated p42/44 MAP kinase. As expected, PMA caused rapid activation (30 s) of erk1/erk2 (Fig. 7) . In analogous experiments, PMA was unable to cause p38 MAP kinase activation at these early time points; however, dual phosphorylation of p38 MAP kinase was initiated after 2 min of PMA treatment (results not shown).
Inhibition of ionomycin-induced tyrosine phosphorylation by p38 MAP kinase antagonism. Ionomycin is known to cause tyrosine phosphorylation of a number of proteins in PMNs (4). To investigate whether these tyrosine-phosphorylated proteins may be downstream of p38 MAP kinase activation, PMNs were pretreated with DMSO, 1 M SB-203580 to inhibit p38 MAP kinase, or 10 M PD-98590 to inhibit p42/44 MAP kinases for 30 min and then stimulated with 2 M ionomycin for 60 s. The proteins from these whole cell lysates were separated by 5-15% SDS gradient polyacrylamide electrophoresis, transferred to nitrocellulose, and immunoblotted with an anti-phosphotyrosine antibody. Ionomycin caused tyrosine phosphorylation of a number of proteins, but especially those at molecular weights of 72 and 105 kDa, respectively, compared with DMSO-pretreated, buffer-stimulated controls (Fig. 8) . Preincubation with SB-203580 inhibited tyrosine phosphorylation of both the 72-and 105-kDa proteins, while pretreatment with PD-98058 had no effect (Fig. 8) . Thus ionomycin-induced tyrosine protein phosphorylation in human PMNs demonstrated at least two protein substrates that are dependent on activation of the p38 MAP kinase cascade for phosphorylation of tyrosine residues.
Manipulation of cytosolic Ca 2ϩ with thapsigargin. To rule out the possibility that ionophores cause intrinsic activation of non-Ca 2ϩ -linked signaling pathways, the cellular effects of thapsigargin were investigated. Thapsigargin is an inhibitor of the endoplasmic reticulum ATPase that causes a release of cytoplasmic Ca 2ϩ (10) . Thapsigargin has been reported to rapidly activate p42/44 MAP kinases; thus, for the purpose of these studies, we examined the changes in cytosolic Ca 2ϩ , priming and activation of the PMN oxidase, and dual phosphorylation of p38 MAP kinase (58) . Thapsigargin (1 M) elicited a rapid rise in cytosolic Ca 2ϩ , followed by a sustained increase in cytosolic Ca 2ϩ (Fig.  9A) . The initial rise in cytosolic Ca 2ϩ could not be totally inhibited by pretreatment with EGTA, although it only represented 60-100 nM of a 2,900-nM rise in cytosolic Ca 2ϩ (Fig. 9B) . However, the sustained rise in Ca 2ϩ , which is a reflection of recruitment of Ca 2ϩ from the extracellular stores, was severely attenuated by preincubation with 5 mM EGTA. Therefore, thapsigargin causes a small but reproducible release of Ca 2ϩ from the calciosomes followed by prolonged Ca 2ϩ influx through extracellular channels.
The effects on the PMN oxidase were then investigated, and thapsigargin alone was not sufficient to activate the respiratory burst of quiescent PMNs (thapsigargin: 0.1 ϩ 0.1 vs. DMSO control: 0.1 ϩ0.1 nmol O 2 Ϫ /min, n ϭ 5). However, thapsigargin pretreatment (5 min) primed the FMLP-activated respiratory burst by 6.2 Ϯ 2.3-fold compared with DMSO-treated control PMNs (n ϭ 5; P Ͻ 0.05). Additionally, thapsigargin caused rapid (60 s) dual phosphorylation of p38 MAP kinase (Fig. 10) . Thus manipulation of cytosolic Ca 2ϩ with thapsigargin, which primes the PMNs and is not structurally related to ionomycin, resulted in activation of p38 MAP kinase.
DISCUSSION
Many studies have documented the requirements of Ca 2ϩ in signal transduction and the normal physiological response of PMNs, including oxidase activation, chemotaxis, the increased surface expression of cell adhesion molecules, and bactericidal activity (21, 42) . The observed increases in cytosolic Ca 2ϩ concentration resulting from PMN agonist stimulation may arise from extracellular Ca 2ϩ transported into the PMN by a receptor-mediated process or the release of intracellular Ca 2ϩ stores (15, 30, 38) . In addition to the role of Ca 2ϩ in PMN physiology, other investigators have demonstrated the relative importance of the p38 and p42/44 MAP kinase pathways in regulating neutrophil function (32, 39, 40) . Inhibition of the p38 MAP kinase attenuates antimicrobial PMN functions such as superoxide generation, increased surface expression of cell adhesion molecules, and chemotaxis (39, 46) . Conversely, divergent results have been published on the role of the p42/44 MAP kinase pathway in regulating PMN function, especially with regard to superoxide generation, chemotaxis, and degranulation (8, 12, 33) . While the importance of intracellular Ca 2ϩ flux has been documented in tyrosine phosphorylation of PMN whole cell extracts (20, 45) , it has been suggested that intracellular Ca 2ϩ is not required or necessary for p38 MAP kinase phosphorylation or activation (32 dual phosphorylation of p42/44 MAP kinase occurred at 200 nM-2 M. Identical concentrations of ionomycin that caused dual phosphorylation also caused activation of both p38 and p42/44 MAP kinases, employing immunoprecipitation of the active enzyme followed by in vitro phosphorylation of a known substrate. Thus we have correlated dual phosphorylation of the p38 and p42/44 MAP kinases with enzymatic activity. Moreover, SB-203580 inhibition of p38 MAP kinase attenuated the ionomycin activation of the PMN oxidase and caused dephosphorylation of two different tyrosinephosphorylated proteins of 72 and 105 kDa. p38 MAP kinase-mediated tyrosine phosphorylation of "downstream" substrates is not surprising, because p38 MAP kinase is at least partially responsible for activation of phospholipase C-␥ by tyrosine phosphorylation in PMNs and is directly involved in the tyrosine phosphorylation of the signal transducer and activator of transcription-1 (STAT1) and the tyrosine phosphatase SHP-2 in COS-7 cells exposed to hyperosmolarity (5, 25) . In contrast, inhibition of p42/44 MAP kinase activation did not affect the PMN oxidase or the tyrosine phosphorylation of PMN proteins. Furthermore, there did not appear to be any "cross talk" between the p38 and p42/44 MAP kinase activation pathways, because the MEK1 inhibitor PD-98059 had no effect on dual phosphorylation of p38 MAP kinase nor the downstream tyrosine-phosphorylated substrates. In analogous studies, SB-203580 had no effect on dual phosphorylation of the p42/44 MAP kinase. These results show not only a dependence of p38 MAP kinase activity for oxidase activation and protein tyrosine phosphorylation in PMNs but also provide additional support for other studies that have concluded that p42/44 MAP kinase phosphorylation is not required for activation of the respiratory burst (33, 46) . The function of p42/44 MAP kinase activation, which may occur simultaneously to p38 MAP kinase activation, in response to ionomycin, remains unclear.
Cytosolic Ca 2ϩ appears to be required for activation of p38 MAP kinase in response to not only ionomycin but also to both FMLP and PAF. Ionomycin, FMLP, and PAF all demonstrated that increases in cytosolic Ca 2ϩ from calciosomes were prerequisite for p38 MAP kinase activation through BAPTA chelation studies. Furthermore, Ca 2ϩ from the extracellular milieu does not affect p38 MAP kinase activity, as demonstrated by studies with EGTA. In addition, the experiments with thapsigargin provide supportive evidence that changes in cytosolic Ca 2ϩ cause activation of the p38 MAP kinase. Thapsigargin, an inhibitor of the endoplasmic reticulum Ca 2ϩ -ATPase, directly increased cytosolic Ca 2ϩ from both intracellular and extracellular stores and caused priming of the FMLP-activated respiratory burst and dual phosphorylation of p38 MAP kinase similar to ionomycin. In contrast, maximal activation of the p42/44 MAP kinases required changes in cytosolic Ca 2ϩ , but it is likely that the source of the Ca 2ϩ was from extracellular "stores", because both EGTA and BAPTA had similar inhibitory effects on p42/44 MAP kinase activation. It is important to note that the dose of BAPTA employed has the capacity to rapidly chelate virtually all of the Ca 2ϩ that accumulates in the cytosol irrespective of its source, either calciosomes or extracellular stores. Conversely, FMLP 
